167 related articles for article (PubMed ID: 31307633)
1. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
Xu C; Sun H; Du S; Xin J
Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of diffusion-weighted magnetic resonance imaging and
Park JJ; Kim CK; Park BK
Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089
[TBL] [Abstract][Full Text] [Related]
4. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
[TBL] [Abstract][Full Text] [Related]
5. Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
Zhu L; Zhu L; Shi H; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X; Liu T
BMC Cancer; 2016 Feb; 16():79. PubMed ID: 26860361
[TBL] [Abstract][Full Text] [Related]
6. Predicting and Early Monitoring Treatment Efficiency of Cervical Cancer Under Concurrent Chemoradiotherapy by Intravoxel Incoherent Motion Magnetic Resonance Imaging.
Zhu L; Zhu L; Wang H; Yan J; Liu B; Chen W; He J; Zhou Z; Yang X
J Comput Assist Tomogr; 2017; 41(3):422-429. PubMed ID: 27824669
[TBL] [Abstract][Full Text] [Related]
7. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
Zheng X; Guo W; Dong J; Qian L
Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
[TBL] [Abstract][Full Text] [Related]
9. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
Vojtíšek R; Baxa J; Kovářová P; Almortaza A; Hošek P; Sukovská E; Tupý R; Ferda J; Fínek J
Strahlenther Onkol; 2021 Jun; 197(6):494-504. PubMed ID: 33492444
[TBL] [Abstract][Full Text] [Related]
10. Relationship between
Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
[TBL] [Abstract][Full Text] [Related]
11. Association between IVIM parameters and treatment response in locally advanced squamous cell cervical cancer treated by chemoradiotherapy.
Perucho JAU; Wang M; Vardhanabhuti V; Tse KY; Chan KKL; Lee EYP
Eur Radiol; 2021 Oct; 31(10):7845-7854. PubMed ID: 33786654
[TBL] [Abstract][Full Text] [Related]
12. Comparison of FDG PET metabolic tumour volume versus ADC histogram: prognostic value of tumour treatment response and survival in patients with locally advanced uterine cervical cancer.
Ueno Y; Lisbona R; Tamada T; Alaref A; Sugimura K; Reinhold C
Br J Radiol; 2017 Jul; 90(1075):20170035. PubMed ID: 28508679
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks TI; von Eyben R; Hristov D; Kidd EA
Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic value of intravoxel incoherent motion (IVIM) MR imaging in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.
Zhu L; Wang H; Zhu L; Meng J; Xu Y; Liu B; Chen W; He J; Zhou Z; Yang X
Sci Rep; 2017 Sep; 7(1):11635. PubMed ID: 28912536
[TBL] [Abstract][Full Text] [Related]
15. Early response of patients undergoing concurrent chemoradiotherapy for cervical cancer: a comparison of PET/CT and MRI.
Lee JE; Huh SJ; Nam H; Ju SG
Ann Nucl Med; 2013 Jan; 27(1):37-45. PubMed ID: 23054833
[TBL] [Abstract][Full Text] [Related]
16. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
[TBL] [Abstract][Full Text] [Related]
18. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
19. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors.
Zhang Y; Zhang K; Jia H; Xia B; Zang C; Liu Y; Qian L; Dong J
Magn Reson Imaging; 2022 Sep; 91():37-44. PubMed ID: 35568271
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]